Skip to content

Longitudinal Follow Up of Subjects Enrolled in Randomized Trial of Prenatal and Infancy Home Visitation

Longitudinal Follow Up of Subjects Enrolled in Randomized Trials of Prenatal and Infancy Home Visitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00443638
Acronym
ElmiraY19
Enrollment
320
Registered
2007-03-06
Start date
1998-05-31
Completion date
2000-04-30
Last updated
2013-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reproductive Behavior, Risk Reduction Behavior

Brief summary

The Elmira follow-up study is designed to assess the extent to which prenatal and infancy home visitation by nurses affects the life-course development of 19-year-old youth whose mothers received those services during pregnancy and the first two years of the child's life.

Interventions

Nurse home visitation

Sponsors

Smith-Richardson Foundation
CollaboratorUNKNOWN
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women prior to the 25th week of gestation * no previous live births * one of the following sociodemographic risk characteristics: * young age (\< 19 years at registration); * unmarried * low socioeconomic status (Medicaid status or no private insurance)

Design outcomes

Primary

MeasureTime frame
rates of pregnancy and out-of-wedlock child birthAt age 19
educational achievement, including graduation from high school and participation in various types of post-high school educationAt age 19
participation in the work force, including enrollment in the armed servicesAt age 19
use of welfareAt age 19
use of substances (cigarettes, alcohol, and illegal drugs)At age 19
involvement with the criminal justice system (arrests, convictions, incarcerations, etc.)At age 19

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026